A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.
CompletedNCT00293163
Genzyme, a Sanofi CompanyFacial Wrinkles
Start: 2006-02-28End: 2006-10-31Target: 120Updated: 2015-03-05